![Michael Richman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Richman
Fondateur chez
NEXTCURE, INC.
Fortune : 226 973 $ au 31/08/2026
Profil
Mr. Michael S.
Richman is a President, Chief Executive Officer & Director at NextCure, Inc. He is on the Board of Directors at NextCure, Inc. Mr. Richman was previously employed as a Chairman by GenVec, Inc., an Independent Director by Pieris Pharmaceuticals, Inc., a Member-Supervisory Board by Pieris AG, a President & Chief Executive Officer by Amplimmune, Inc., an Independent Director by Opexa Therapeutics, Inc., a Chief Operating Officer & Executive Vice President by MacroGenics, Inc., a SVP-Corporate Development & Administration by MedImmune LLC, and a Director-Corporate Business Development by Chiron Corp.
He also served on the board at Madison Vaccines, Inc., PharmaFrontiers Corp., Cougar Biotechnology, Inc. and Cougar Biotechnology, Inc. /Old/.
He received his undergraduate degree from the University of California, Davis and a graduate degree from San Francisco State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEXTCURE, INC. 0,78% | 22/04/2026 | 35 520 ( 0,78% ) | 226 973 $ | 31/08/2026 |
Postes actifs de Michael Richman
| Sociétés | Poste | Début |
|---|---|---|
| NEXTCURE, INC. | Fondateur | 01/12/2015 |
Anciens postes connus de Michael Richman
| Sociétés | Poste | Fin |
|---|---|---|
| PIERIS PHARMACEUTICALS | Directeur/Membre du Conseil | 13/12/2024 |
Madison Vaccines, Inc.
 Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for patients with prostate cancer | Directeur/Membre du Conseil | 01/01/2024 |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Directeur/Membre du Conseil | 19/09/2017 |
| GENVEC INC | Président | 16/06/2017 |
Amplimmune, Inc.
 Amplimmune, Inc. BiotechnologyHealth Technology Develops immune-based biological treatments | Directeur Général | 01/07/2015 |
Formation de Michael Richman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Amplimmune, Inc.
Amplimmune, Inc. BiotechnologyHealth Technology Develops immune-based biological treatments | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
PharmaFrontiers Corp.
 PharmaFrontiers Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris AG
 Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Health Technology |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Madison Vaccines, Inc.
Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for patients with prostate cancer | Health Technology |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
